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We are proud to announce the re-launch of Hereditary
Cancer in Clinical Practice (HCCP). Moving from a classi-
cal printed journal, first published in 2003, to the open
access, online format of BioMed Central will allow for a
quicker and much wider distribution of published arti-
cles. Further improving exposure of articles, the journal
has also been accepted for indexing by PubMed, and is
now on track to receive it's first Impact Factor in 2010 after
being accepted for inclusion in Thomson Reuters' Science
Citation Index Expanded and the Journal Citation
Reports. In addition, the Editorial Board of the journal has
been expanded in acknowledgement of the continuing
growth of the field of clinical cancer genetics.
Much has changed since December 2003 when the first
paper issue of HCCP was published. New genes and syn-
dromes have been identified, more molecular pathways
have been unraveled, and new knowledge on therapeutic
and preventive options has been gained. However, the
reasons for publishing HCCP remain unchanged: to con-
tribute to the improvement of care for individuals and
families who are genetically predisposed to develop can-
cer. As before, this journal will try to cover relevant topics
from multiple perspectives, including those of researchers
and medical practitioners from different parts of the
world who may have different scientific interests and
medical priorities. We also remain dedicated to support
the international discussion on important topics by send-
ing out questionnaires to the field and publishing their
results.
We invite you and your colleagues to submit your manu-
scripts to HCCP, ranging from small but illustrative case
reports to larger scientific studies. In addition to these
types of articles, the reader may expect to see meeting
reports, reviews and commentaries to highlight new
developments and existing controversies in the field.
We hope you will enjoy reading the new Hereditary Cancer
in Clinical Practice.
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